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It Can Be Done!*Michael Mack, MDP roviding optimal access to care for complexmedical procedures frequently bumps upagainst the inconvenient reality of the rela-
tionship between procedural volumes and the out-
comes achieved. This volume-outcome relationship
has been extensively studied and documented to be
present on both a hospital and individual operator
basis for complex surgical procedures (1). As a general
rule, the more complex the procedure, the more that
experience and the number performed matter. The
experience gained from repeated performance is not
limited to just the technical expertise of performing
the procedure, but more holistically applies to all
aspects of the health care ecosystem in which the
procedure is performed. This includes prompt timely
access to care, appropriate patient selection, post-
procedure and post-discharge care, and follow-up.SEE PAGE 1944With this background in mind, in this issue of
JACC: Cardiovascular Interventions, Stub et al. (2)
from British Columbia have published the outcomes
of a regional system of care for transcatheter aortic
valve replacement (TAVR) in their province. The
study was led by Dr. Webb, a pioneer of this catheter-
based approach for treating elderly, inoperable, and
high surgical-risk patients with severe aortic stenosis (3).
He performed the ﬁrst procedure by a retrograde
approach from the femoral artery in Vancouver in
2006, and for the next 6 years, all patients undergoing
the procedure in British Columbia were treated in a*Editorials published in JACC: Cardiovascular Interventions reﬂect the
views of the authors and do not necessarily represent the views of JACC:
Cardiovascular Interventions or the American College of Cardiology.
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reported that he has no relationships relevant to the contents of this
paper to disclose.single center. However, as with most new procedures
introduced into medicine, incremental improvements
in devices and techniques occur, learning curves are
surmounted, and the procedures become more pa-
tient and operator friendly. As a consequence, the
treatment can potentially be expanded to a wider
group of patients in more diverse clinical settings.
Therefore, in 2012, the British Columbia Provincial
Health Services Authority established a province-
wide transcatheter heart valve program expanding
the performance of TAVR to 3 additional sites. While
all sites performed selected transfemoral (TF) pro-
cedures in native valve aortic stenosis, non-TF
approaches, valve-in-valve procedures, and patients
deemed to be at high risk were treated only in the
reference center. Furthermore, the experienced
reference center participated in mentoring, patient
selection, and proctoring of the newer sites. The
authors present the outcomes achieved over the ﬁrst
3 years of the program and concluded that the excel-
lent outcomes achieved province-wide demonstrated
the potential beneﬁts of a regional system of care.
The authors and the health care authorities in
British Columbia are to be congratulated for such a
rational and thoughtful approach to health care,
balancing ﬁrst and foremost superior outcomes with
expanded access to care, which is a not insigniﬁcant
issue in this elderly population living across a large
geographic area.
One is left however, wanting to know more details
on how the program works and why it is successful!
How many procedures were performed in the newer
lower-volume centers, and what were the outcomes
there? Was the Vancouver program really translatable
to other sites? What was the evolution of the program
in the reference center as the more straightforward,
lower-risk patients were treated in other centers?
Presumably, a lot of management skills, bureaucratic
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1953maneuvering, and countless meetings were necessary
to implement and maintain the program.
One key question that the authors raise in their
limitations is whether this model is expandable to
other health care systems in other countries. Indeed,
is the development of this regional “hub and spoke”
system successful mainly because it is embedded in a
universal health care system, or can it be replicated in
some form in other health care venues? How much of
a role did visionary caregivers and health policy
leaders play in bringing all the stakeholders to the
table and implementing such a system, and can this
paradigm be reproduced elsewhere?
TAVR was introduced commercially in the United
States in late 2011 in a manner termed by Ralph Brindis
as “rational dispersion” (4). The primary payer of these
procedures in the United States, the Centers for Medi-
care andMedicaid Services, consulted the professional
societies, the American College of Cardiology, and the
Society of Thoracic Surgeons for advice as to how
this new procedure should be integrated into the U.S
health care system. The resultant National Coverage
Determination set forth criteria that centers and opera-
tors were required tomeet as a condition of payment (5).
It was envisioned that approximately 400 of the
1,600 cardiac catheterization laboratories and 1,200
cardiac surgery programswould qualify. Indeed today,
4 years after introduction, the Society of Thoracic
Surgeons/American College of Cardiology TVT (Trans-
catheter Valve Therapy) Registry reports that over
35,000 procedures have been performed in approxi-
mately 400 centers in 49 states, with generally good
outcomes and acceptable geographic access to care (6).
So, where do we go from here in the United States,
and what can we learn from the British Columbia pro-
gram that can be implemented in this country? A new
report has indicated that there is a volume-outcome
relationship with TAVR (7). A current analysis is un-
derway in the TVT Registry to verify this initial report
from the National Inpatient sample. Because we do not
have a universal health care system in the UnitedStates, the British Columbia program cannot be exactly
replicated in this country. However, many aspects of it
can. For example, the cardiac surgeons and interven-
tional cardiologists in Michigan have long-standing,
successful, statewide programs for cardiac surgery
and percutaneous coronary intervention. They are
now working together on a statewide TAVR program.
Although thiswill not be possible inmost states or even
most large metropolitan areas, there is an ongoing
amalgamation of hospitals regionally into large health
care systems that could adopt many of the aspects of
the British Columbia regional program. Indeed, a
number of these systems, including Dartmouth-
Hitchcock Medical Center, the Johns Hopkins Hospital
and Health System, and the University of Michigan
Health System, have recently announced a “Take the
Volume Pledge” campaign (8). In this program, 10
complex surgical procedures would only be performed
in hospitals within their system meeting certain
volume metrics. One could envision a similar program
for TAVR within health care systems or regions where
lower-risk TF approaches could be done in regional
programs, whereas higher-risk, more complex, non-
TF, and valve-in-valve cases would be performed
only in hub reference centers under an integrated,
programmatic approach, thereby achieving a balance
between access to care and quality outcomes.
The clinicians and health policy experts in British
Columbia are to be congratulated for their visionary
and balanced approach to the introduction of this
new lifesaving procedure in a careful manner that
provides wide access to care while not compromising
the excellent outcomes. One can only hope that this
program serves as a bellwether for the implementa-
tion of a similar care model in the United States and in
other parts of the world.
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